UnitedHealth names Witty as Optum CEO; Gilead R&D chief to exit; Novartis ups chief digital officer to executive committee.
Direct-to-consumer drug marketing spend dropped most heavily in the magazine and digital categories.
Health's popularity at SXSW continues to build. Here's our opening weekend wrap-up.
Regeneron, Sanofi cut cost of Praluent for wider coverage; GSK to maintain Advair exclusivity for 2018; 'Right to try' bill introduced in House.
White House quashes Idaho's insurance plans; Voyager reports positive results in clinical trial for Parkinson's drug; Cigna-Express Scripts deal to face long review.
Now more than ever, patients aren't shy about sharing their wants and needs. Here, 8,000 patients from three generations in the U.S., U.K., Germany, and France weigh in on everything from brand loyalty to the factors that drive their decision-making-processes to the reasons they switch treatments.
She was one of the firm's original staffers in 2013.
The NY-based shop is known as BX: Brand Experience Design Group.
Cigna to buy Express Scripts for $52B; Gottlieb says 'rigged' system is keeping drug prices high; Sanofi, Evotec speed up infectious disease research.
As oncology drugs save or extend the lives of many more patients than anyone could have imagined a few years ago, a new challenge has emerged in the wake of their approval: Selling them to patients scared about their prognosis and alternately ignorant of and skeptical about recent breakthroughs in treatment.
FDA approves 23andMe breast cancer test, with a warning; Novartis partners with Science 37 on clinical trials using mobile devices; European regulator calls for suspension of Zinbryta.
When Ortho Clinical Diagnostics lived under the roof of Johnson & Johnson, it had the luxury of focusing on its product and service mix — and not a whole lot else.
He was previously a managing partner at Ogilvy CommonHealth.
Pharma has backed a number of AR-based games for physician learning and marketing. They're meant to complement live learning, but mobile games may do a better job teaching certain skills.
Mesara previously worked in communications for pharma companies AbbVie, Abbott, and Pfizer.
UnitedHealth to pass on rebates to customers; Arkansas adds Medicaid work requirements; American College of Physicians reveals Type 2 diabetes guidelines.
The firm recently brought on SVPs in its Washington and Boston offices.
Dermira likely to shelve experimental acne drug; Biotech companies apply to use Crispr gene-editing tool; Another setback for Santhera's Raxone.
The pharmaceutical company is undergoing a global restructuring as it relaunches its brand in the U.S. and Canada.
The results will appear in MM&M's Agency A-to-Z directory, which will appear in the magazine's July issue.
Uber rolls out rides to doctor appointments; Trump calls for federal suit against opioid makers; Biogen, AbbVie pull marketing for Zinbryta.
The firm has named Oliver Caporn and Debra Polkes to new roles.
The Cannes Lions Health jury leaders also explained changes to the awards at an event in New York this week.
WPP segment including health and wellness outperforms rest of holding company in Q4; Novartis partners with Pear on app development; Study: 3 million-plus Americans could join association health plans in four years.
From Muse: Michelle Obama on making consumers comfortable with med tech (and thinking before she tweets)
The former first lady spoke at Klick Health's Muse event, which also featured panels on gene therapy, health technology, and immunotherapy.
FDA declines to review potential Celgene MS blockbuster; AstraZeneca to spin off autoimmune drug unit; Justice Department to back prescription opioid lawsuit.
Heal CEO Nick Desai aims to improve the patient experience by providing an on-demand service that cuts time and costs while increasing human interaction.
Boston Children's Hospital and Klick Health are unveiling a VR tool to help pediatric patients visualize their disease and symptoms. It could augment the paper-based standard of care.
Apple plans California healthcare clinics for staff; Aldeyra strikes inflammatory disease drug pact with J&J; 20 states sue feds to end Obamacare.
The platform is looking to focus its communications strategy on the U.S. market.
FDA approves KemPharm's Apadaz; Buffett says healthcare alliance will do more than cut out middlemen; Customers unhappy with price of Teva's Syprine generic.
Virta Health CEO Sami Inkinen on changing patient behavior: 'We're cutting down trees in the wrong forest'
Seven questions for the Virta Health chief executive and cofounder of Trulia.
Read the February 2018 issue in its entirety.
Pharma buys back shares with tax savings; Facebook algorithm change means opportunity for patient influencers; Trump claims Azar has already lowered drug prices.
A WEGO Health white paper examined how the change could affect patient influencers.
Novo Nordisk diabetes pill delivers in late-stage trial; Gilead partners with Sangamo on engineered cell therapies; Study finds antidepressants work, though with varying results.
Dohmen will continue to operate under its brand and retain its leadership team.
The new HHS secretary has been given a difficult task by President Trump: bring drug prices down.
AbbVie reports successful elagolix trial; White House touts short-term insurance plans; Mayo Clinic chief to retire.
Talukdar will lead the firm's advisory practice, VantageRx.
Gilead wins reversal of $2.5 billion payment order; Aimmune Therapeutics' peanut allergy therapy shows promise; AstraZeneca wins FDA approval on key cancer drug.
Roche to acquire Flatiron Health for $1.9B; FDA considers allowing pre-symptom Alzheimer's drug tests; Marijuana producer branches into pharma.
The agency began working with the national reproductive center this month.
CMS forecasts prescription drug spending to hit $5.7T by 2026; Ipsen predicts cancer drug shopping spree; Omnicom numbers miss estimates on revenue.
The two organizations will partner on content including personal stories and expert advice.
In 2017, Interpublic reported a net income of $579 million, down 4.8% from the previous year.
IPG 2017 net income drops; Bristol-Myers Squibb inks $1.85 billion deal with Nektar on cancer drug; Merck halts final-stage Alzheimer's drug.
Daniel Carucci is joining the Interpublic Group firm full-time after serving as a consultant and in roles with the U.N. Foundation and the U.S. Navy.
The company is also looking to better combine its web and social media presence.
Zimprich joins from Honeywell, where he led global business communications.
Amazon moves into medical supply market; Big Pharma gets a tax cut; Former Celgene CEO plans Senate run.
There was so much bigger-picture coverage of pharma and healthcare in 2017 - pricing, Affordable Care Act reform and repeal - that it was easy to lose sight of everything else. PwC's Health Research Institute has used its annual look-ahead report to spotlight a handful of undercover trends.
The pharma company manufactures the well-known opioid OxyContin.
Healthcare providers may understand its importance, but across the board not many are ready to meet the requirements of the program QPP, according to a study.
As the evidence mounts that high-deductibles don't cause patients to shop or save for healthcare, payers are taking note.
White House limits guidance documents; Top executives exit Axovant; Carroll nominated as drug czar.
More has been written about millennials — and their healthcare habits — than about any other generation. Here, Gen Y marketers explain why most of what you've read is wrong.
Study: Two prostate cancer drugs delay metastasis by two years; Budget deal funds CHIP for four years; Azar outlines Trump's drug pricing plans.
PhRMA wants to clear the air about drug pricing with the consumer-focused extension of the Let's Talk About Cost campaign.
Critics said the initial spots unnecessarily blamed IBD sufferers.
FDA approval of Gilead HIV drug prompts ViiV patent suit; Poll shows split in voter reaction to Trump opioid plan; Outcome Health partners with CDC.
Zero people have such tales about Robert Leverte, which is why news of his pending induction into the Medical Advertising Hall of Fame was received warmly when it was made public last October.
We asked some of the agency world's sharpest data people to answer a pair of questions about the future of data in and around pharma marketing. Here's what they had to say.
Study casts doubt on employee wellness programs; FDA identifies kratom as an opioid; House passes bill to modify ACA restaurant menu rules.
In the past, pharma hasn't used data effectively to engage its A-list HCPs. Five companies hope to change that.
LiquidHub formed a health- and life-sciences-focused offering last June after acquiring Eveo.
Burcin, who joins from Klick Health, is the former Global CEO of Havas Health.
The agency M&A market is changing as the big ad groups have been "distracted" by internal restructuring and new acquirers are emerging.
Allergan Q4 earnings beat estimates; Mars publishes research policies; Conway takes control of White House opioid agenda.
Snow Companies, which emphasizes patient storytelling, was founded by Brenda Snow in 2001.
McCann Worldwide has sent a memo to staff to encourage them to speak up if they face a 'behaviour or concern' in the workplace.
Opdivo hits key goal in late-stage trial; Philippines government sues Sanofi over anti-dengue vaccine; hospitals reach capacity amid record flu season.
Fueled by system-wide demand and facilitated by AI, the industry's lofty expectations around real-world evidence could soon be fulfilled
This year, the Super Bowl and World Cancer Day fall on the same date.
AstraZeneca strikes deals with Alibaba, Tencent; NY AG sues opioid maker; Justice Department wants more info on CVS-Aetna deal.
Spark has priced its cure for a rare form of blindness at $425,000 per eye. But rather than the science or the cost, pharma is buzzing over the company's outcomes-based pricing model
Amazon's ability to attract other employers makes its healthcare coalition very formidable, experts say
Details are vague, but the e-commerce giant indicated it's serious about getting into healthcare.
The network also appointed her predecessor, Nick Colucci, as COO of Publicis Communications North America, effective immediately.
Childs has worked at the network news division for more than a decade.
Vertex moves two cystic fibrosis drugs into Phase III trials; American Heart Association says breast cancer survivors have higher risk of cardiovascular disease; Blood test to predict Alzheimer's shows promise.
Glaze worked in Edelman's market access practice for more than seven years.
Strategies for differentiating CAR-T therapies emerge in the early days of 2018, while competitors race to catch up with Novartis and Gilead.
The nonprofit worked with creative agency E/LA on the push.
Four data aces share their backgrounds, inspirations, and guiding philosophies
CDC chief resigns; Amazon healthcare entry raises data concerns; Trump promises to make lower drug prices 'a priority'
Burson-Marsteller has appointed MSLGroup's EMEA head of healthcare to lead its own health practice in the UK, PRWeek has learned.
Jardiance treats patients with type 2 diabetes and heart disease, lowering blood sugar and reducing the risk of death from heart disease.
Amazon, Berkshire Hathaway, and JPMorgan team up to form a healthcare company; Takeda's Zika vaccine receives FDA fast-track status
Publicis Groupe has announced it has selected Microsoft has the technology partner to deliver its artificial intelligence platform Marcel.
Alan Maine has joined Edelman as a senior director in its London health team.
Outcome Health settles fraud allegations, reassigns leaders; Approval of generics surges during first year of Trump administration; Sanofi acquires coveted biotech firm.
WPP was brought on to help with consumer education about the food industry.
For some pharma brands, the price tag is just too high. For others, the platform isn't serious enough.
Read the January 2018 issue in its entirety.
Pharma groups upped lobbying spend in 2017; Novartis, Bayer heads dine with Trump at Davos; Illumina wins jury verdict against Roche subsidiary
Fidelino served on the Health & Wellness jury in 2015 and the Pharma jury last year. Levy has been a member of both Health category juries and was a speaker at the first Health Lions in 2014.
Somatix is a digital health platform that tracks movements through smartwatches.
Senate confirms Azar as HHS head; Spark licenses Luxturna to Novartis outside the U.S.; Glaxo and J&J top index of superbug combatants
Warc anticipates global adspend growth this year to ring in at a healthy 4.7%, or $572bn (£410bn).
WPP has become embroiled in a row over sexism and misogyny following an exposé into the lewd behaviour of a men-only event sponsored by the advertising giant in London.